Results 71 to 80 of about 1,157 (167)

Direct antiglobulin test in the differential diagnosis of ABO hemolytic disease of the newborn: an important tool with high negative predictive value

open access: yesHematology, Transfusion and Cell Therapy
Background: Hemolysis due to ABO incompatibility is an important differential diagnosis in newborns presenting with jaundice. Clinical studies evaluating ABO hemolytic disease of fetus and newborn (ABO-HDFN) question the diagnostic value of the direct ...
Samira Ali Abbas   +8 more
doaj   +1 more source

Anti‐Erythrocyte Antibody Formation in Individuals With and Without Known Sensitisation Pathways Reflecting Indications for Extended Immunohaematology Screening

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 20, October 2026.
– The yearly incidence of anti‐red blood cell antibodies stratified by participant groups and temporal evolution. – Overall significance p = 3.756 × 10−29. ABSTRACT Background Blood transfusion therapies are of vital importance for many patient groups.
Milanka Milosavić   +3 more
wiley   +1 more source

Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review

open access: yes, 2022
The primary objective was to explore perinatal and neonatal outcomes amongst infants who received intrauterine transfusion (IUT) for the management of hemolytic disease of the fetus and newborn (HDFN).
Ursula Blyth (13818087)   +4 more
core   +1 more source

Analysis of laboratory tests and prevention strategies for hemolytic disease of the fetus and newborn caused by anti-M

open access: yesZhongguo shuxue zazhi
Objective To analyze the application of serological test results in the diagnosis and treatment of anti-M-induced hemolytic disease of the fetus and newborn(HDFN), and to explore HDFN prevention strategies.
Hecai YANG   +7 more
doaj   +1 more source

Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

open access: yes
Transfusion, EarlyView.
Nabiha H. Saifee   +24 more
wiley   +1 more source

Massive fetomaternal hemorrhage and successful prevention of maternal RhD alloimmunization: A case report

open access: yesTransfusion, Volume 66, Issue 10, Page 2017-2024, October 2026.
Abstract Background Massive fetomaternal hemorrhage can lead to significant fetal morbidity or mortality. RhD negative patients require appropriate treatment to prevent alloimmunization in subsequent pregnancies. Few cases with follow‐up into future pregnancies have been reported.
Sajjad Hassan   +4 more
wiley   +1 more source

Unraveling complexity: A case report on ABO hemolytic disease of the fetus newborn in a preterm neonate and delayed hemolytic transfusion reaction in the beta thalassemic mother due to alloanti kidd a antibody

open access: yesAsian Journal of Transfusion Science
ABO hemolytic disease of the fetus and newborn (HDFN) generally occurs due to transplacental passage of maternal IgG ABO antibodies causing fetal and newborn red cell hemolysis.
V. K. Nayana   +5 more
doaj   +1 more source

Hemolytic disease of the fetus and newborn: A review of pathophysiology, diagnosis, and management

open access: yes
Hemolytic Disease of the Fetus and Newborn (HDFN) results from maternal alloantibodies attacking fetal red blood cells, leading to fetal anemia and potentially severe complications such as hydrops fetalis.
Malik, Hajram   +2 more
core   +1 more source

Serologic Reactivity of Unidentified Specificity in Antenatal Testing and Hemolytic Disease of the Fetus and Newborn: The BEST Collaborative Study

open access: yes, 2023
BACKGROUND: The clinical significance of serologic reactivity of unidentified specificity (SRUS) in pregnancy is not clear based on available literature.
Pagano, Monica B   +20 more
core  

Noninvasive approach for the management of hemolytic disease of the fetus

open access: yes, 2009
Hemolytic disease of the fetus and newborn (HDFN) is due to maternal alloantibodies directed against paternally inherited antigens on fetal red cells, and it is still a problem in affected pregnancies despite the routine use of anti-D immunoglobulin ...
Soothill, PW   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy